Financhill
Back

Intellia Therapeutics Vs. Editas Medicine Industry Stock Comparison

Sell
34

NTLA
Intellia Therapeutics

Last Price:
16.70
Seasonality Move:
10.47%
Buy
54

EDIT
Editas Medicine

Last Price:
3.12
Seasonality Move:
16.26%
Sell
34
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $16.73. The Score for NTLA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Editas Medicine (EDIT) is a Buy

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • EDIT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $16.73
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing buying pressure, which is a positive indicator for future bullish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.12 Sell
Relative Strength Index (14 RSI): 45.46 Sell
Chaikin Money Flow: 1491336 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.28 - 19.6) Sell
Bollinger Bands (100): (18.39 - 24.77) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 46.22 Sell
Chaikin Money Flow: -650602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3 - 3.38) Sell
Bollinger Bands (100): (3.24 - 4.92) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.34 Buy
20-day SMA: 17.34 Sell
50-day SMA: 19.21 Sell
200-day SMA: 23.59 Sell
8-day EMA: 15.99 Buy
20-day EMA: 16.89 Sell
50-day EMA: 18.83 Sell
200-day EMA: 23.7 Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.05 Buy
20-day SMA: 3.2 Sell
50-day SMA: 3.4 Sell
200-day SMA: 5.44 Sell
8-day EMA: 3.12 Buy
20-day EMA: 3.18 Sell
50-day EMA: 3.47 Sell
200-day EMA: 5.22 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and a decrease next year of $0.22 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and an increase next year of $0.23 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):